Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
About us The Bioelectronics group at UCL's Department of Electronic and Electrical Engineering is seeking a postdoctoral researcher to join a flagship EPSRC-funded project led by Dr Yu Wu. This is a
-
vision, machine learning, computational imaging, surgical data science, biomedical engineering, medical image computing or a closely related discipline. They should have strong knowledge of AI, computer
-
31 Jul 2026 Job Information Organisation/Company UCL EE Department Electronic and Electrical Engineering Research Field Engineering » Electrical engineering Engineering » Electronic engineering
-
are recruiting a Lecturer/Assistant Professor or Associate Professor who applies cutting-edge machine learning, artificial intelligence and related computational biology to fundamental biological problems. About
-
29th September 2026 Languages English English Norsk Nynorsk English PhD position on AI Ethics in Human-AI Constellations at AI LEARN Apply for this job See advertisement UiB - Knowledge that shapes
-
matching, optimal transport or cell-cycle modelling. Key Responsibilities These include but are not limited to: Leading an independent research project in scientific machine learning and mechanistic
-
. The Financial Computing & Analytics Group is a leading research hub at the intersection of finance, data science, and technology. The group specialises in quantitative finance, machine learning, blockchain, and
-
the position by the start of the 2026-27 academic year (September 2026). UCL is one of the foremost universities in Britain and the world. The Department of Electronic and Electrical Engineering at UCL is
-
. Contribute to the ongoing development of VISIBLE as an AI-enabled platform for experimental biology. About you You will have: PhD in computer science, data science, machine learning, computational biology
-
Essential PhD in immunology, hematology, molecular biology, stem cell biology, gene therapy, or a related discipline, achieved as at the fund’s start date (September 7, 2026) Strong experience in CAR T-cell